• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人内皮细胞合成并释放ADAMTS - 13。

Human endothelial cells synthesize and release ADAMTS-13.

作者信息

Turner N, Nolasco L, Tao Z, Dong J-F, Moake J

机构信息

Department of Bioengineering, Rice University, Houston, TX 77005, USA.

出版信息

J Thromb Haemost. 2006 Jun;4(6):1396-404. doi: 10.1111/j.1538-7836.2006.01959.x.

DOI:10.1111/j.1538-7836.2006.01959.x
PMID:16706987
Abstract

Hepatic stellate cells have been considered to be a primary source for human plasma ADAMTS-13, the von Willebrand factor (VWF)-cleaving metalloprotease. In this study, ADAMTS-13 antigen was detected by immunofluorescence in both venous (HUVECs) and arterial endothelial cells (HUAECs) using both polyclonal antibodies made against peptides found in various domains of human ADAMTS-13, as well as by a monoclonal antibody against the ADAMTS-13 metalloprotease domain. ADAMTS-13 antigen had an intra-cellular distribution in endothelial cells distinct from the Weibel-Palade body location of VWF, and was released from the cells during 48 h in culture. The mRNA for ADAMTS13 was detected in HUVECs and HUAECs using reverse transcription-polymerase chain reaction (RT-PCR), indicating that the enzyme is synthesized in these cells. The ADAMTS-13 protein was immunoprecipitated from HUVECs and had an approximate M(r) of 170 kDa, similar to the molecular mass of recombinant ADAMTS-13. The ADAMTS-13 in HUVEC and HUAEC lysates had enzymatic activity using both static and flow assays. We conclude that ADAMTS-13 is synthesized in human endothelial cells, and released constitutively. The vast number of endothelial cells in the body may be an important source of ADAMTS-13.

摘要

肝星状细胞被认为是人类血浆中血管性血友病因子裂解金属蛋白酶ADAMTS - 13的主要来源。在本研究中,使用针对人类ADAMTS - 13不同结构域中发现的肽段制备的多克隆抗体以及针对ADAMTS - 13金属蛋白酶结构域的单克隆抗体,通过免疫荧光法在静脉内皮细胞(HUVECs)和动脉内皮细胞(HUAECs)中检测到了ADAMTS - 13抗原。ADAMTS - 13抗原在内皮细胞中的细胞内分布与血管性血友病因子(VWF)的魏尔-帕拉德小体位置不同,并且在培养48小时期间从细胞中释放出来。使用逆转录-聚合酶链反应(RT-PCR)在HUVECs和HUAECs中检测到了ADAMTS13的mRNA,表明该酶在这些细胞中合成。从HUVECs中免疫沉淀出的ADAMTS - 13蛋白的近似分子量为170 kDa,与重组ADAMTS - 13的分子量相似。使用静态和流动分析方法,HUVEC和HUAEC裂解物中的ADAMTS - 13具有酶活性。我们得出结论,ADAMTS - 13在人内皮细胞中合成并组成性释放。体内大量的内皮细胞可能是ADAMTS - 13的重要来源。

相似文献

1
Human endothelial cells synthesize and release ADAMTS-13.人内皮细胞合成并释放ADAMTS - 13。
J Thromb Haemost. 2006 Jun;4(6):1396-404. doi: 10.1111/j.1538-7836.2006.01959.x.
2
Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage.内皮细胞 ADAMTS-13 和 VWF:产生、释放和 VWF 多聚体裂解。
Blood. 2009 Dec 3;114(24):5102-11. doi: 10.1182/blood-2009-07-231597. Epub 2009 Oct 12.
3
Disulfide bond reduction of von Willebrand factor by ADAMTS-13.血管性血友病因子的二硫键由 ADAMTS-13 还原。
J Thromb Haemost. 2010 Dec;8(12):2778-88. doi: 10.1111/j.1538-7836.2010.04094.x.
4
Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate.以重组血管性血友病因子A2结构域多肽为底物评估血浆中ADAMTS-13活性。
Thromb Haemost. 2003 Dec;90(6):1204-9. doi: 10.1160/TH03-06-0398.
5
Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets.人血小板中血管性血友病因子裂解蛋白酶(ADAMTS-13)的检测
Biochem Biophys Res Commun. 2004 Jan 2;313(1):212-6. doi: 10.1016/j.bbrc.2003.11.111.
6
Production, crystallization and preliminary crystallographic analysis of an exosite-containing fragment of human von Willebrand factor-cleaving proteinase ADAMTS13.人血管性血友病因子裂解蛋白酶ADAMTS13含外部位点片段的产生、结晶及初步晶体学分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jul 1;65(Pt 7):739-42. doi: 10.1107/S1744309109023410. Epub 2009 Jun 30.
7
VWF and ADAMTS13 behavior in estradiol-treated HUVEC.雌激素处理的 HUVEC 中 VWF 和 ADAMTS13 的行为。
Eur J Haematol. 2011 Feb;86(2):140-7. doi: 10.1111/j.1600-0609.2010.01545.x. Epub 2010 Dec 29.
8
Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.血红蛋白通过 ADAMTS-13 阻断血管性血友病因子的蛋白水解:与镰状细胞病相关的一种机制。
Thromb Haemost. 2009 Jun;101(6):1070-7.
9
Crystal structure and enzymatic activity of an ADAMTS-13 mutant with the East Asian-specific P475S polymorphism.具有东亚特异性 P475S 多态性的 ADAMTS-13 突变体的晶体结构和酶活性。
J Thromb Haemost. 2013 Jul;11(7):1399-406. doi: 10.1111/jth.12279.
10
siRNA-knockdown of ADAMTS-13 modulates endothelial cell angiogenesis.ADAMTS-13的小干扰RNA敲低调节内皮细胞血管生成。
Microvasc Res. 2017 Sep;113:65-70. doi: 10.1016/j.mvr.2017.05.007. Epub 2017 May 22.

引用本文的文献

1
Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity.PRMT1介导的精氨酸甲基化影响ADAMTS13的分泌及酶活性。
Arterioscler Thromb Vasc Biol. 2025 Apr;45(4):506-522. doi: 10.1161/ATVBAHA.124.322249. Epub 2025 Feb 13.
2
ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy.ADAMTS13改善糖尿病视网膜病变中的内皮功能并减轻炎症。
Cells. 2025 Jan 9;14(2):85. doi: 10.3390/cells14020085.
3
Animal models for thrombotic thrombocytopenic purpura: a narrative review.血栓性血小板减少性紫癜的动物模型:一项叙述性综述。
Ann Blood. 2023 Sep 30;8. doi: 10.21037/aob-22-18. Epub 2022 Nov 16.
4
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura.新兴遗传性血栓性血小板减少性紫癜治疗方法的作用新机制。
Expert Rev Hematol. 2024 Jul;17(7):341-351. doi: 10.1080/17474086.2024.2356763. Epub 2024 May 20.
5
Endotoxemia and Platelets: 2 Players of Intrahepatic Microthrombosis in NAFLD.内毒素血症与血小板:非酒精性脂肪性肝病肝内微血栓形成的两个因素
JACC Basic Transl Sci. 2023 Sep 27;9(3):404-413. doi: 10.1016/j.jacbts.2023.07.003. eCollection 2024 Mar.
6
Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection.血浆血管性血友病因子和含血小板解聚蛋白及金属蛋白酶13的动态评估可预测新型冠状病毒肺炎住院患者的死亡率
J Clin Med. 2023 Nov 19;12(22):7174. doi: 10.3390/jcm12227174.
7
Injury-induced endotheliopathy: What you need to know.损伤诱导的血管内皮病变:你需要了解的知识。
J Trauma Acute Care Surg. 2023 Oct 1;95(4):454-463. doi: 10.1097/TA.0000000000004082. Epub 2023 Jun 12.
8
A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen-deuterium exchange plus mass spectrometry.氢氘交换质谱法揭示的ADAMTS-13变构调节潜在新机制
Res Pract Thromb Haemost. 2022 Dec 13;7(1):100012. doi: 10.1016/j.rpth.2022.100012. eCollection 2023 Jan.
9
Mechanisms of ADAMTS13 regulation.ADAMTS13 的调控机制。
J Thromb Haemost. 2022 Dec;20(12):2722-2732. doi: 10.1111/jth.15873. Epub 2022 Sep 22.
10
ADAMTS13 protease or lack of von Willebrand factor protects irradiation and melanoma-induced thrombotic microangiopathy in zebrafish.ADAMTS13 蛋白酶或缺乏血管性血友病因子可保护斑马鱼的辐射和黑色素瘤诱导的血栓性微血管病。
J Thromb Haemost. 2022 Oct;20(10):2270-2283. doi: 10.1111/jth.15820. Epub 2022 Aug 7.